StemCell Therapy

More than 10% of people with diabetes and COVID-19 receive ventilator intubation and die within a week of hospitalization, say investigators. Higher body weight is independently linked to these outcomes, while glucose control is not, they report.

Diabetes is a known contributor to COVID-19 severity, but the characteristics that predict adverse outcomes in diabetes patients have been unclear, wrote Bertrand Cariou, M.D., Ph.D., from the University of Nantes, France. In a new study, Cariou and colleagues found that 10.6% of 1,317 participants died within seven days of hospital admission. And the higher a patients body mass index, the greater their risk.

A number of other factors also predicted seven-day mortality at admission. These included labored breathing, lymphocyte (white blood cell) count levels, and the presence of inflammation and liver damage markers.

In contrast, factors that had no significant bearing on seven-day intubation and mortality included age, sex, long-term glucose control, chronic complications, and hypertension or usual medications.

Only BMI turned out to be independently associated with the primary outcome, Cariou wrote. Each increase in BMI is associated with an increase in the risk of intubation and/or death in the seven days following admission for COVID-19. So lets target this population as a really important population to keep social distancing and stay alert on avoiding the virus.

The study was published Friday in the journal Diabetologia.

Go here to read the rest:
One in ten with diabetes die within week of COVID-19 hospitalization: Weight a key factor - Clinical Daily News - McKnight's Long Term Care News

This entry was posted on June 2, 2020 at 8:46 pm and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |